Management seems to think a restructuring will help the company, cutting jobs, splitting the Cardiac Rhythm Unit (which makes Pacemakers and Defibrillators) from its Interventional Cardiology Business, (they make stents).
Even with those changes, I don't see any big rally's in the near future, barring any big news events.
Even the board pumpers have dropped their targets.
Back in Feb & March, richey was trying to convince the board we would be at the $7 level by April. Someone else was looking for $10-$12.
And looking back to March, we had one poster pumping a $60 price target: